CAPITAL VENTURES INTERNATIONAL filings

This page lists the SEC filings reported by CAPITAL VENTURES INTERNATIONAL.

SEC filings by CAPITAL VENTURES INTERNATIONAL (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2008-02-04CAPITAL VENTURES INTERNATIONAL /E9/DAYSTAR TECHNOLOGIES INC2,499,4007.7%EDGAR
SC 13G/A2008-02-04CAPITAL VENTURES INTERNATIONAL /E9/TAPESTRY PHARMACEUTICALS, INC1,571,8778.9%EDGAR
SC 13G/A2008-02-04CAPITAL VENTURES INTERNATIONAL /E9/GLG Partners LP207,0866.8%EDGAR
SC 13G/A2008-02-04CAPITAL VENTURES INTERNATIONAL /E9/BEACON POWER CORP7,770,9828.2%EDGAR
SC 13G/A2008-02-04CAPITAL VENTURES INTERNATIONAL /E9/TOREADOR RESOURCES CORP1,023,6665.3%EDGAR
SC 13G2007-11-30CAPITAL VENTURES INTERNATIONAL /E9/TXCO Resources Inc2,561,5337.1%EDGAR
SC 13G2007-11-05CAPITAL VENTURES INTERNATIONAL /E9/DAYSTAR TECHNOLOGIES INC2,500,0007.7%EDGAR
SC 13G2007-10-17CAPITAL VENTURES INTERNATIONAL /E9/CHINA MEDICINE CORP1,100,0008.3%EDGAR
SC 13G2007-09-11CAPITAL VENTURES INTERNATIONAL /E9/BEACON POWER CORP5,077,1946.7%EDGAR
SC 13G2007-04-02CAPITAL VENTURES INTERNATIONAL /E9/TOREADOR RESOURCES CORP1,066,6665.6%EDGAR
SC 13G2007-03-23CAPITAL VENTURES INTERNATIONAL /E9/eFuture Information Technology Inc.200,0807.1%EDGAR
SC 13G/A2007-02-13CAPITAL VENTURES INTERNATIONAL /E9/MECHANICAL TECHNOLOGY INC2,488,5147.9%EDGAR
SC 13G/A2007-02-13CAPITAL VENTURES INTERNATIONAL /E9/TAPESTRY PHARMACEUTICALS, INC1,687,5469.9%EDGAR
SC 13G/A2007-02-13CAPITAL VENTURES INTERNATIONAL /E9/DISCOVERY LABORATORIES INC /DE/4,333,0076.2%EDGAR
SC 13G/A2007-02-08CAPITAL VENTURES INTERNATIONAL /E9/IMMUNOGEN INC3,090,2497.4%EDGAR
SC 13G/A2007-02-07CAPITAL VENTURES INTERNATIONAL /E9/IMMUNOGEN INC3,089,4497.4%EDGAR
SC 13G2006-12-26CAPITAL VENTURES INTERNATIONAL /E9/MECHANICAL TECHNOLOGY INC2,777,7788.1%EDGAR
SC 13G2006-12-01CAPITAL VENTURES INTERNATIONAL /E9/DISCOVERY LABORATORIES INC /DE/4,629,6306.7%EDGAR
SC 13G2006-06-09CAPITAL VENTURES INTERNATIONAL /E9/TAPESTRY PHARMACEUTICALS, INC1,691,4959.9%EDGAR
SC 13G/A2006-02-14CAPITAL VENTURES INTERNATIONAL /E9/IMMUNOGEN INC3,403,9258.3%EDGAR
Form 13F-HR
The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
Form SC 13D/G
Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
Form 3, 4, and 5
Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.